On November 9, 2020, Synalloy Corp. announced the acquisition of DanChem, a leading full-service specialty chemicals manufacturer, for approximately $1.2 billion.  According to the company's press release announcing the acquisition, DanChem is uniquely positioned to capitalize on the demand for high-quality, high-quality products.  The company's Board of Directors previously approved the acquisition.  According to the SEC's complaint filed in federal court in Alexandria, Virginia, DanChem is uniquely positioned to capitalize on demand for high-quality, high-quality, and low-cost products.  According to the SEC's complaint, DanChem's capacity to produce high-quality, high-quality products has been limited by supply chain and labor constraints.  The SEC's complaint, filed in federal court in Alexandria, Virginia, charges DanChem with violating the antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.  Without admitting or denying the allegations in the SEC's complaint, DanChem has agreed to the entry of a final judgment that permanently enjoins it from violating the antifraud provisions of Sections 17(a)(1) and (3) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder. The final judgment also prohibits DanChem from violating the antifraud provisions of Sections 206(1) and 206(2) of the Investment Advisers Act of 1940 and Rule 206(4)-8 thereunder.  The SEC's investigation was conducted by Ashley Tam of the Market Abuse Unit in the New York Regional Office, and the litigation will be handled by Mr. Tam and Ms. Tam.  The SEC appreciates the assistance of the U.S. Attorney's Office for the Eastern District of Virginia, the Federal Bureau of Investigation, and the Financial Industry Regulatory Authority.